Skip to main content
. 2019 May 29;81(7):1034–1039. doi: 10.1292/jvms.19-0019

Fig. 3.

Fig. 3.

Human epidermal growth factor receptor 2 (HER2) expression in the primary tumor (A) and metastatic lymph node (B) by flow cytometric analysis (gray dotted line: negative control, black solid line: trastuzumab). The tumor cells from both the primary tumor and metastatic lymph node were positive for HER2, and trastuzumab could bind to canine anal sac gland carcinoma cells.